Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
CA Regulators Complete Review of Wildfire Risk Model California’s Department of Insurance has completed a review of the state’s first wildfire catastrophe model, which property/casualty insurers...
Trump Administration’s ‘AI Action Plan’ Targets State AI Regulation The Trump administration released an “AI Action Plan,” aimed at speeding the development of artificial...
In the span of just 36 days this spring and summer, the number of states offering unemployment benefits to striking workers doubled—to four. New Jersey was the first to offer such benefits, beginning...
Developing Anti-‘Debanking’ Trend in Red States? A new front appears to have opened in the ongoing battle over environmental, social and governance (ESG) investing. In March Idaho Gov. Brad...
FL Requests Medicaid Waiver to Bolster Health Workforce Florida is seeking a federal waiver to use Medicaid funding to expand its health care workforce, a plan that could be adopted by other states....
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
North Carolina Gov. Roy Cooper (D) announced last week that the state will launch Medicaid expansion on Dec. 1, which will leave just 10 states that haven’t opted to expand Medicaid under the Affordable Care Act. North Carolina’s expansion is expected to provide coverage for about 600,000 more residents. (ASSOCIATED PRESS)
Nebraska Gov. Jim Pillen (R) issued an executive order providing Medicaid coverage to women for up to a year after they’ve given birth, doubling the six months of postpartum coverage provided by legislation enacted in June (LB 227). The state joins a growing list of GOP-led states that have embraced expanded postpartum Medicaid coverage since the Supreme Court overturned Roe v. Wade. (ASSOCIATED PRESS, OMAHA WORLD-HERALD, STATE NET)
The FDA approved a series of safety-related labeling changes for Novo Nordisk’s diabetes—and now popular weight-loss—drug Ozempic, including a notification that the drug has been associated with reports of ileus, a potentially life-threatening blockage of the intestines. Similar so-called GLP-1 agonist medications Wegovy, also made by Novo Nordisk, and Mounjaro, from Eli Lilly, already acknowledge such reports in their labeling. (CBS NEWS)
Minnesota, Washington, the District of Columbia, Massachusetts and Colorado received top marks in AARP’s 2023 LTSS State Scorecard, which measures the performance of state long-term services and support systems. The states with the lowest performing LTSS systems were Tennessee, Mississippi, South Carolina, Alabama and West Virginia. (AARP)
—Compiled by SNCJ Managing Editor KOREY CLARK